Related Experiment Video
Updated: Mar 17, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise
N Milman1,2,3, A Boonen4, P Tugwell1,3,5
1a Division of Rheumatology , Ottawa Hospital , Ottawa , Canada.
Clinical experts identified key domains for assessing anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) impact. This research aims to improve outcome measures by including patient and clinician perspectives.
Area of Science:
- Rheumatology
- Clinical Outcomes Research
- Health Services Research
Background:
- Current outcome measures for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) require stakeholder input.
- The Outcome Measures in Rheumatology (OMERACT) initiative sets standards for outcome measurement.
Purpose of the Study:
- To identify domains important for assessing AAV impact from a clinical expert perspective.
- To utilize the International Classification of Functioning, Disability and Health (ICF) framework.
- To incorporate stakeholder views into AAV outcome measurement.
Main Methods:
- An international Delphi questionnaire was used.
- Clinicians with AAV expertise were identified via vasculitis societies.
- A three-round e-mail-based survey was conducted.
Main Results:
- 41 out of 82 invited clinicians responded.
- Nineteen domains were deemed important by over 80% of participants.
- Key domains included body functions (e.g., energy, pain), body structures (e.g., lungs, kidneys), activities/participation (e.g., daily routine, employment), and environmental factors (e.g., medications, health services).
Conclusions:
- Clinical experts prioritize AAV's physiological effects over its impact on daily life and contextual factors.
- This study is a step toward a more comprehensive, stakeholder-informed approach to AAV assessment.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Nephrotic Syndrome II : Assessment and Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Aneurysm II: Clinical Manifestations and Diagnostic Studies

